Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 4/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 2/20 | 0.33 |
| ▸ | MMP8 | P22894 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12028322 | 0.89 | MAOA (0.38) | ELANEMAOAMAOBSIGMAR1 | |
| SCHEMBL12027484 | 0.80 | ELANE (0.42) | ELANETP53MAOAMAOBGRIN2B | |
| SCHEMBL12028209 | 0.76 | — | — | |
| SCHEMBL9267924 | 0.70 | CYP1A2 (0.46) | — | |
| SCHEMBL22770702 | 0.68 | ELANE (0.34) | ELANE | |
| SCHEMBL2618046 | 0.67 | CYP2A6 (0.31) | — | |
| SCHEMBL9982961 | 0.67 | MMP2 (0.35) | ELANETP53MMP2MMP9MMP8 | |
| SCHEMBL12027481 | 0.66 | CES1 (0.31) | — | |
| SCHEMBL9378728 | 0.66 | KCNQ2 (0.60) | — | |
| SCHEMBL9983294 | 0.66 | ELANE (0.32) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2397475-B1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2014-11-12 | — | — | EP | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | UNIVERSITEIT HASSELT (BE) | 2011-12-22 | — | — | US | disclosed |
| EP-2397475-A1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2011-12-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313175-A1 | 4, 4' DISUBSTITUTED 4H-CYCLOPENTADITHIOPHENE AND NEW METHODS FOR SYNTHESISING THE SAME | DDT, NISCH, DBH | ELANE 2336/4885NPSR1 950/4885TP53 1962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.